This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Aug:216:A1-A2.

doi: 10.1016/j.ajo.2020.03.029. Epub 2020 May 8.

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?

Michael F Marmor¹

Affiliations

PMID: 32439074
PMCID: PMC7205730
DOI: 10.1016/j.ajo.2020.03.029

Editorial

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?

Michael F Marmor. Am J Ophthalmol. 2020 Aug.

. 2020 Aug:216:A1-A2.

doi: 10.1016/j.ajo.2020.03.029. Epub 2020 May 8.

Author

Michael F Marmor¹

Affiliation

¹ Department of Ophthalmology and Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California. Electronic address: marmor@stanford.edu.

PMID: 32439074
PMCID: PMC7205730
DOI: 10.1016/j.ajo.2020.03.029

No abstract available

PubMed Disclaimer

Similar articles

Hydroxychloroquine and ritonavir for COVID-19 infection: a possible synergic toxicity for retinal pigmented epithelium.
Romano MR, Raimondi R, Montericcio A, Allegrini D. Romano MR, et al. Graefes Arch Clin Exp Ophthalmol. 2020 Dec;258(12):2871. doi: 10.1007/s00417-020-04727-3. Epub 2020 May 8. Graefes Arch Clin Exp Ophthalmol. 2020. PMID: 32385749 Free PMC article. No abstract available.
Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
Islam M. Islam M. J Coll Physicians Surg Pak. 2020 Jun;30(6):78. doi: 10.29271/jcpsp.2020.Supp1.S78. J Coll Physicians Surg Pak. 2020. PMID: 32723461 No abstract available.
COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
Marmor MF. Marmor MF. Am J Ophthalmol. 2020 May;213:A3-A4. doi: 10.1016/j.ajo.2020.03.028. Epub 2020 Mar 25. Am J Ophthalmol. 2020. PMID: 32247518 Free PMC article. No abstract available.
Of chloroquine and COVID-19.
Touret F, de Lamballerie X. Touret F, et al. Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5. Antiviral Res. 2020. PMID: 32147496 Free PMC article. Review.
Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
Marouf BH, Dizaye K. Marouf BH, et al. Drug Discov Ther. 2020;14(3):109-116. doi: 10.5582/ddt.2020.03035. Drug Discov Ther. 2020. PMID: 32669519

See all similar articles

Cited by

Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.
Gegúndez-Fernández JA, Zarranz-Ventura J, Garay-Aramburu G, Muñoz-Negrete FJ, Mendicute Del Barrio J, Pablo-Júlvez L, García-Delpech S, López-Alemany A, Arnalich-Montiel F, Cordero-Coma M, Cárceles JA; Sociedades oftalmológicas españolas. Gegúndez-Fernández JA, et al. Arch Soc Esp Oftalmol (Engl Ed). 2020 Jun;95(6):300-310. doi: 10.1016/j.oftal.2020.04.002. Epub 2020 Apr 25. Arch Soc Esp Oftalmol (Engl Ed). 2020. PMID: 32409243 Free PMC article. Review.
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.
Sharun K, Tiwari R, Yatoo MI, Natesan S, Megawati D, Singh KP, Michalak I, Dhama K. Sharun K, et al. Narra J. 2022 Dec;2(3):e92. doi: 10.52225/narra.v2i3.92. Epub 2022 Dec 8. Narra J. 2022. PMID: 38449903 Free PMC article. Review.

References

1. Devaux C.A., Rolain J.-M., Colson P., Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105938. - DOI - PMC - PubMed
1. Gao J., Zhenxue T., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends. 2020;14:72–73. - PubMed
1. Harrison C. Coronavirus puts drug repurposing on the fast track. Nat Biotechnol. 2020;38:379–381. - PubMed
1. Marmor M., Kellner U., Lai T.Y., Melles R.B., Mieler W.F. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision) Ophthalmology. 2016;123:1386–1394. - PubMed
1. Furst D.E., Lindsley H., Baethge B. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. Semin Arthritis Rheum. 1999;42:357–365. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information